Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
AstraZeneca
Baxter
Colorcon
Express Scripts

Last Updated: October 6, 2022

Patent: 4,456,544


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 4,456,544
Title: Enzyme-containing detergent composition for presterilization treatment of medical instruments and equipment
Abstract:An enzyme-containing detergent composition for a presterilization treatment of medical instruments and equipment, consisting of the following components, percent by weight: anionic surfactants: 4.0-6.0 sodium phosphate: 30.0-35.0 sodium silicate: 20.0-25.0 sodium carbonate: 19.0-22.0 soap comprising sodium salts of fatty acids: 2.0-4.0 enzymatic preparation: 0.5-2.0 sodium sulphate: the balance, the enzymatic preparation having the following composition, percent by weight: alkaline protease: 30-60 neutral protease: 27-45 elastase: 0.01-5.00 collagenase: 0.001-4.00 leucinaminopeptidase: 0.0001-0.011 carboxypeptidase: 0.04-0.15 fibrinolytic enzyme: 0.002-1.500 lipase: 0.5-2.0 amylase: the balance.
Inventor(s): Lupova; Ljudmila M. (Moscow, SU), Fedorova; Lidia G. (Moscow, SU), Grebeshova; Renata N. (Moscow, SU), Aleshina; Zinaida P. (Moscow, SU), Anton; Alexandr G. (Moscow, SU), Belinsky; Alexandr L. (Moscow, SU), Alexeeva; Margarita I. (Moscow, SU)
Assignee: Vsesojuzny Nauchno-Issledovatelsky Biotecknichesky Institut (Moscow, SU)
Application Number:06/520,813
Patent Claims:see list of patent claims

Details for Patent 4,456,544

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Smith & Nephew, Inc. SANTYL collagenase Ointment 101995 06/04/1965 See Plans and Pricing 2039-03-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Boehringer Ingelheim
Moodys
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.